Spaderizine en es it fr

Spaderizine Brand names, Spaderizine Analogs

Spaderizine Brand Names Mixture

  • No information avaliable

Spaderizine Chemical_Formula

C26H28N2

Spaderizine RX_link

No information avaliable

Spaderizine fda sheet

Spaderizine msds (material safety sheet)

Spaderizine Synthesis Reference

No information avaliable

Spaderizine Molecular Weight

368.514 g/mol

Spaderizine Melting Point

No information avaliable

Spaderizine H2O Solubility

750 mg/L

Spaderizine State

Solid

Spaderizine LogP

5.63

Spaderizine Dosage Forms

No information avaliable

Spaderizine Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Spaderizine Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Spaderizine Absorption

No information avaliable

Spaderizine side effects and Toxicity

No information avaliable

Spaderizine Patient Information

No information avaliable

Spaderizine Organisms Affected

Humans and other mammals